Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rixa Health vs TRYM Health

Rixa Health
Graded #320

Lower grade

vs+13.299999999999997
TRYM Health
Graded #67

Higher grade

The verdict

TRYM Health takes it — 73.8/100 to 60.5/100.

TRYM Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TRYM Health (TRYM) is a nationwide telehealth service offering compounded GLP-1 weight-loss medication — semaglutide (~$96/mo, $3.20/day) and tirzepatide (~$126/mo, $4.20/day) — as additive-free multi-dose…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTRYM Health +51
45
96
Dose & formulationTRYM Health +21
51
72
Clinical oversightRixa Health +14
85
71
Labs & monitoringRixa Health +10
63
53
FulfillmentRixa Health +4
78
74
Contract termsTRYM Health +14
41
55
Rixa Health · left barTRYM Health · right bar

The numbers

MetricRixa HealthTRYM Health
WeighScore60.5/10073.8/100
GradeCC
Scorecard rank#320#67
SemaglutideNot disclosed$96/mo (all doses, compounded)
TirzepatideNot disclosed$126/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Rixa Health

Graded #320 · C

Strengths

  • Functional-medicine, root-cause clinical approach
  • Compounded and oral semaglutide plus tirzepatide offered
  • Board-certified DO and FNP providers with years of experience
  • Medication bundled with visits into a single price
  • No charge until after approval

Where it loses points

  • No public monthly pricing; quoted only during consultation
  • Relies on compounded GLP-1, which is not FDA-approved as a finished drug
  • A handful of states still listed as coming soon
  • Branded GLP-1 medications are not the primary offering
  • Requires ongoing monthly follow-up commitment
TRYM Health

Graded #67 · C

Strengths

  • Affordable compounded GLP-1 — semaglutide ~$96/mo ($3.20/day) and tirzepatide ~$126/mo ($4.20/day)
  • Available in all 50 states with free shipping and FSA/HSA eligibility
  • Multi-dose vials cover all doses up to the maximum; additive-free, with a full starter kit
  • Temperature-controlled insulated shipping and flexible cancellation

Where it loses points

  • Compounding pharmacy partner not named
  • Not LegitScript-certified (no certification displayed)
  • Lowest per-day pricing likely requires a longer prepaid plan commitment
  • Drugs labeled generically as 'GLP-1' / 'GLP-1 + GIP' on the services page rather than named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard